ConductScience.org, home

Paper34100716

Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy.

Uehara H and 16 others. Elife, 2021. Cited by 45 papers, by iCite.

Cite this record

ConductScience Library. Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy. Papers, record 34100716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34100716

Download JSON
Cell line
NIH 3T3264 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy.
PubMed
Journal
Elife
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
2.96
iCite
Revised in PubMed
2024-05-05
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Uehara HHironorihttps://orcid.org/0000-0001-6133-4918
2Zhang XXiaohui
3Pereira FFelipe
4Narendran SSiddharth
5Choi SSusie
6Bhuvanagiri SSai
7Liu JJinlu
8Ravi Kumar SSangeetha
9Bohner AAustin
10Carroll LLara
11Archer BBonnie
12Zhang YYue
13Liu WWei
14Gao GGuangping
15Ambati JJayakrishna
16Jun ASAlbert S
17Ambati BKBalamurali K

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CRISPR-Cas SystemsMajor topic
Codon, InitiatorMajor topic
Fuchs' Endothelial DystrophyMajor topic
Gene EditingMajor topic
Animals
Collagen Type VIII
Disease Models, Animal
Male
Mice
Mice, Inbred C57BL
RNA, Guide, CRISPR-Cas Systems

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 EY017950NEI NIH HHSUnited StatesR01EY017950PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134100716Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy.Elife2021https://conductscience.org/library/papers/34100716PubMed
228358029Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy.Nat Commun2017https://conductscience.org/library/papers/28358029PubMed
323422828L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23422828PubMed
425322173Factors associated with corneal graft survival in the cornea donor study.JAMA Ophthalmol2015https://conductscience.org/library/papers/25322173PubMed
516051690Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye.FASEB J2005https://conductscience.org/library/papers/16051690PubMed
622002996An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis.Hum Mol Genet2012https://conductscience.org/library/papers/22002996PubMed
711157802Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).Hum Mol Genet2001https://conductscience.org/library/papers/11157802PubMed
823110055Differing roles for TCF4 and COL8A2 in central corneal thickness and fuchs endothelial corneal dystrophy.PLoS One2012https://conductscience.org/library/papers/23110055PubMed
96700727Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo.Nature1984https://conductscience.org/library/papers/6700727PubMed
1023287722RNA-guided human genome engineering via Cas9.Science2013https://conductscience.org/library/papers/23287722PubMed
1111689488Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.Hum Mol Genet2001https://conductscience.org/library/papers/11689488PubMed
1220036349Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p.Am J Hum Genet2010https://conductscience.org/library/papers/20036349PubMed
1322956607Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy.Invest Ophthalmol Vis Sci2012https://conductscience.org/library/papers/22956607PubMed
1422998502Confirmation of the association between the TCF4 risk allele and Fuchs endothelial corneal dystrophy in patients from the Midwestern United States.Ophthalmic Genet2013https://conductscience.org/library/papers/22998502PubMed
1524763830Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcome.JAMA Ophthalmol2014https://conductscience.org/library/papers/24763830PubMed
1629966009Gene expression in the corneal endothelium of Fuchs endothelial corneal dystrophy patients with and without expansion of a trinucleotide repeat in TCF4.PLoS One2018https://conductscience.org/library/papers/29966009PubMed
1717546019A protocol for rapid generation of recombinant adenoviruses using the AdEasy system.Nat Protoc2007https://conductscience.org/library/papers/17546019PubMed
1826937169Fuchs endothelial corneal dystrophy: current perspectives.Clin Ophthalmol2016https://conductscience.org/library/papers/26937169PubMed
1931469403Gene Expression and Missplicing in the Corneal Endothelium of Patients With a TCF4 Trinucleotide Repeat Expansion Without Fuchs' Endothelial Corneal Dystrophy.Invest Ophthalmol Vis Sci2019https://conductscience.org/library/papers/31469403PubMed
2022715153The KAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms.Hum Mutat2012https://conductscience.org/library/papers/22715153PubMed

See all 36 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
42930058Gene Therapy for Corneal Diseases.BioTech (Basel)2026https://conductscience.org/library/papers/42930058PubMed
42675489Targeting LRPPRC to improve corneal wound healing via augmenting autophagy and suppressing TGF-β/Smad signaling post-alkali burn.J Transl Med2026https://conductscience.org/library/papers/42675489PubMed
42627922RNA delivery to the corneal endothelium using charge-altering releasable transporters.Sci Adv2026https://conductscience.org/library/papers/42627922PubMed
42397667Association between subjective symptoms and severity in patients with Fuchs endothelial corneal dystrophy.Jpn J Ophthalmol2026https://conductscience.org/library/papers/42397667PubMed
42278622Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases.Int J Mol Sci2026https://conductscience.org/library/papers/42278622PubMed
41900769Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy.Pharmaceutics2026https://conductscience.org/library/papers/41900769PubMed
41850243Targeted AAV6 gene therapy restores corneal endothelial function in three hereditary corneal dystrophies.Cell Rep Med2026https://conductscience.org/library/papers/41850243PubMed
41820594Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury.Gene Ther2026https://conductscience.org/library/papers/41820594PubMed
41809205Congenital Hereditary Endothelial Dystrophy: A Review of the Molecular Pathogenesis, Genetic Basis, and Emerging Treatments.Clin Ophthalmol2026https://conductscience.org/library/papers/41809205PubMed
41658434Advances and challenges of CRISPR/Cas gene editing for corneal diseases.Adv Ophthalmol Pract Res2026https://conductscience.org/library/papers/41658434PubMed
41641337Type VIII collagen: advances in matrix biology and translational promise.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/41641337PubMed
41328347Advancements in CRISPR-based therapies for ocular pathologies: from disease mechanisms to intervention strategies.Theranostics2026https://conductscience.org/library/papers/41328347PubMed
41283239Emerging Innovations in the Treatment of Fuchs Endothelial Corneal Dystrophy: A Narrative Review.Med Sci (Basel)2025https://conductscience.org/library/papers/41283239PubMed
41153439Genetic Therapy of Fuchs Endothelial Corneal Dystrophy: Where Are We? A Review.Genes (Basel)2025https://conductscience.org/library/papers/41153439PubMed
40924317Correlation between visual function and corneal backscatter by Scheimpflug imaging or anterior segment optical coherence tomography in Fuchs endothelial corneal dystrophy.Jpn J Ophthalmol2025https://conductscience.org/library/papers/40924317PubMed
40650962Developing stem cells for corneal disease: recent developments and future perspectives.Regen Med2025https://conductscience.org/library/papers/40650962PubMed
40202733Iron-Sulfur Clusters and Iron Responsive Element Binding Proteins Mediate Iron Accumulation in Corneal Endothelial Cells in Fuchs Dystrophy.Invest Ophthalmol Vis Sci2025https://conductscience.org/library/papers/40202733PubMed
40002778Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review.Biomedicines2025https://conductscience.org/library/papers/40002778PubMed
39952985Advancements in bioengineering for descemet membrane endothelial keratoplasty (DMEK).NPJ Regen Med2025https://conductscience.org/library/papers/39952985PubMed
39716183A tool for CRISPR-Cas9 sgRNA evaluation based on computational models of gene expression.Genome Med2024https://conductscience.org/library/papers/39716183PubMed

See all 30 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACAN176PubTator's text mininghttps://conductscience.org/library/genes/176NCBI Gene
COL8A21296PubTator's text mininghttps://conductscience.org/library/genes/1296NCBI Gene
KAT6B23522PubTator's text mininghttps://conductscience.org/library/genes/23522NCBI Gene
LMO74008PubTator's text mininghttps://conductscience.org/library/genes/4008NCBI Gene
SRGAP223380PubTator's text mininghttps://conductscience.org/library/genes/23380NCBI Gene
SV2C22987PubTator's text mininghttps://conductscience.org/library/genes/22987NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE146999

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34100716

GET https://conductscience.org/api/papers/v1/34100716/references?page=2